ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Proshares On demand ETF

Proshares On demand ETF (OND)

33.6269
0.229
(0.69%)
Closed January 25 4:00PM
33.5401
-0.0868
(-0.26%)
After Hours: 7:59PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
33.6269
Bid
-
Ask
-
Volume
214
33.54 Day's Range 33.5401
24.3725 52 Week Range 35.5656
Previous Close
33.3979
Open
33.54
Last Trade
100
@
33.6269
Last Trade Time
Average Volume (3m)
756
Financial Volume
$ 7,178
VWAP
33.54

OND Latest News

Loan Facility - Replacement

RNS Number:2784S OverNet Data PLC 20 November 2003 20 November 2003 OverNet Data Plc (the "Company") Loan Facility - Replacement The following replaces the announcement released on...

Loan Facility

RNS Number:1344S OverNet Data PLC 17 November 2003 17 November 2003 OverNet Data Plc (the "Company") Loan Facility The Company has arranged an interest free convertible loan of up to...

Change of Adviser

RNS Number:1144S OverNet Data PLC 14 November 2003 OverNet Data plc Appointment of Nominated Advisor OverNet Data plc has today appointed City Financial Associates Limited as its...

Holding(s) in Company

RNS Number:1743R OverNet Data PLC 22 October 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company OVERNET DATA PLC 2. Name of shareholder having a...

Further re Suspension

RNS Number:1064R OverNet Data PLC 21 October 2003 OVERNET DATA PLC ("OverNet Data" or the "Company") Further to the suspension of trading in the ordinary shares of 0.5 pence in OverNet...

Suspension - OverNet Data PLC

RNS Number:0667R AIM 20 October 2003 NOTICE (407) 20/10/2003 8:30am TEMPORARY SUSPENSION OF TRADING ON AIM OVERNET DATA PLC At the request of the company trading on AIM...

Director Shareholding

RNS Number:8947Q OverNet Data PLC 14 October 2003 OverNet Data PLC 14 October 2003 OverNet Data PLC ('OverNet Data' or the 'Company') OverNet Data has been notified that Mr Leo...

Director Shareholding

RNS Number:7467Q OverNet Data PLC 09 October 2003 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company OVERNET DATA PLC 2. Name of...

Interim Results

RNS Number:8897P OverNet Data PLC 18 September 2003 18 September 2003 OverNet Data plc OverNet Data Announces Interim Results For the six months ended 30 June 2003 OverNet...

Stmnt re Share Price Movement

RNS Number:0191P OverNet Data PLC 26 August 2003 26 August 2003 OverNet Data plc ('the Company') Share price movement The Directors have noted the recent movement in the Company's...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.43691.316360349533.1933.7433.1916933.39469368SP
40.37691.1335338345933.253431.9253833.09795978SP
120.66692.0233616504932.9635.565631.9275634.07254708SP
265.449619.34039102428.177335.565626.696640033.51196618SP
528.626934.50762535.565624.372527731.81324472SP
1564.916917.126088470928.7135.565616.727526925.80480945SP
260-5.6931-14.478891149539.324116.727541330.87928796SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVNINVNI Group Ltd
$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
$ 90.11
(-38.07%)
8
ACONAclarion Inc
$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
$ 142.62
(-3.12%)
232.88M

Discussion

View Full Feed
oldmystic oldmystic 44 seconds ago
I think it is very cool and like it, just not convinced of the value. In corporate life we spent a fair amount of effort on charting software and did extensive studies on TA to determine how much Alfa if any it can provide. The results were not overwhelming, which of course doesn't they can't be for
AVXL
TAB78 TAB78 1 minute ago
I have this a few times, I take it mean company wants us to know what the AS & OS is

I called OTC once and asked about why its updated daily on some, they said it depends on the arrangement between the company and their TA

Since the TA is the one that reports it to OTC
GRLF
Zorax Zorax 1 minute ago
We were already dealing with the highest assault of bird flu ever which was already raising prices.

And with rfk in the health spot, he'll not allow vaccines or studies and wait 5 years for everyone to get sick and die from bird flu because of his belief of a defunct and debunked deca
k9narc k9narc 1 minute ago
I prefer my kale

With a silent K
CanItBThisEZ2Make CanItBThisEZ2Make 2 minutes ago
Thank You, Very Much, That's a straight up $0.43 per share by rough calculations IMO - NFA!

GO $AZRH
AZRH
Invest-in-America Invest-in-America 2 minutes ago
TVGN: Is glorious Microsoft really proactively 'collaborating' with tiny TVGN ; or, is TVGN merely EXPLOITING Microsoft's already-existing AI services & products??? (Be very careful when a little-known company suddenly publishes so-called ' NEWS ' with terms like ' partnering with', or ' tea
TVGN
capgain capgain 2 minutes ago
Tele's and Lucinda, how can you go wrong? :)
KILLAZILLA KILLAZILLA 3 minutes ago
F- CREDIT RATING AND NO POSITIVE INCOME ARE 2 OTHERS....

SHOULD I LIST MORE???

MAMALUKE!!!
WDLF
declaes declaes 3 minutes ago
25,000,000 revenues in 2025!!!

style="font-size: 16px"Based on the prior year revenues in both Kentucky and West Palm Beach, Florida and the addition of the new beds in Boca Raton, Florida, the revenue target for all facilities in the Company for all of 2025 is $25,000,000.00.
GRST
wiwineguy wiwineguy 4 minutes ago
Looks great Mr Chen!  Thank you
TGLO
double_m double_m 4 minutes ago
Real funny when the dreamers show up on this board with posts showing optimism for $MULN. These guys refuse to believe any warnings about this company and its 💩CEO. Most of us have been dealing with Mullen for as much as 3 years and have lost varying amounts of money to the blatant lies and
MULN
ThunderousSeer8 ThunderousSeer8 4 minutes ago
It is tiring even for me seeing him exhausting himself in desperation
RDAR
justhefax justhefax 8 minutes ago
i share the desire for success as i do have a significant stake.
Apart from Schwab i don't see any visible sign of the name change. If any see other places good to know.

I dont see the work you refer to apart from releases going back to spring ( and Schwab). The name change was
KGKG
IhidfromtheX IhidfromtheX 8 minutes ago
Time diagnosed until the average life span for an illness IMO is a great marker...The longer the better...
AVXL
zab zab 9 minutes ago
I have noticed that also, did you see this article.

https://www.seattletimes.com/nation-world/nation/more-dei-fallout-air-force-scraps-course-that-used-videos-of-tuskegee-airmen-and-female-wwii-pilots/

https://www.detroitnews.com/story/news/politics/2025/01/25/air-force
exwannabe exwannabe 10 minutes ago
I think TVO gave end of February as a grace period for some time. Unlike many, he’s willing to say if it goes beyond that, his concern level would increase. Right now, he’s still expecting January (with February as the final grace period). IMO. I pretty much echo his sentiment, based upon his and ly
NWBO
Johnniegalan Johnniegalan 10 minutes ago
JR….tell that to the folks with special insight who have fueled a nearly 50% increase in the price of the stock in the last 3 weeks or so..
AMRN
boi568 boi568 12 minutes ago
If dramatic brain preservation is not a validated biomarker for AD because no other effective drug has achieved the most obviously desirable physical result for this disease, then the FDA should use whatever discretion it enjoys to relax the "validated" requirement here.

Otherwise, w
AVXL